These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11976023)

  • 1. Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate.
    Sallam AS; Khalil E; Ibrahim H; Freij I
    Eur J Pharm Biopharm; 2002 May; 53(3):343-52. PubMed ID: 11976023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water soluble drugs I. Phase behaviour in physiologically-relevant media.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):844-55. PubMed ID: 20636872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phytantriol and glyceryl monooleate cubic liquid crystalline phases as sustained-release oral drug delivery systems for poorly water-soluble drugs II. In-vivo evaluation.
    Nguyen TH; Hanley T; Porter CJ; Larson I; Boyd BJ
    J Pharm Pharmacol; 2010 Jul; 62(7):856-65. PubMed ID: 20636873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats.
    Boyd BJ; Khoo SM; Whittaker DV; Davey G; Porter CJ
    Int J Pharm; 2007 Aug; 340(1-2):52-60. PubMed ID: 17467935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water quantitatively induces the mucoadhesion of liquid crystalline phases of glyceryl monooleate.
    Lee J; Young SA; Kellaway IW
    J Pharm Pharmacol; 2001 May; 53(5):629-36. PubMed ID: 11370702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies.
    Dante MCL; Borgheti-Cardoso LN; Fantini MCA; Praça FSG; Medina WSG; Pierre MBR; Lara MG
    J Pharm Sci; 2018 Mar; 107(3):870-878. PubMed ID: 29108729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of SBA-15 for furosemide oral delivery enhancement.
    Ambrogi V; Perioli L; Pagano C; Marmottini F; Ricci M; Sagnella A; Rossi C
    Eur J Pharm Sci; 2012 May; 46(1-2):43-8. PubMed ID: 22365882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic characterization of swelling of liquid crystalline phases of glyceryl monooleate.
    Lee J; Choi SU; Yoon MK; Choi YW
    Arch Pharm Res; 2003 Oct; 26(10):880-5. PubMed ID: 14609139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies on glycerol monooleate- and phytantriol-based cubosomes containing oridonin in vitro and in vivo.
    Shi X; Peng T; Huang Y; Mei L; Gu Y; Huang J; Han K; Li G; Hu C; Pan X; Wu C
    Pharm Dev Technol; 2017 May; 22(3):322-329. PubMed ID: 26670780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.
    Lian R; Lu Y; Qi J; Tan Y; Niu M; Guan P; Hu F; Wu W
    AAPS PharmSciTech; 2011 Dec; 12(4):1234-40. PubMed ID: 21948306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs.
    Efentakis M; Naseef H; Vlachou M
    Drug Dev Ind Pharm; 2010 Aug; 36(8):903-16. PubMed ID: 20196641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cubic liquid crystalline glyceryl monooleate matrices for oral delivery of enzyme.
    Shah MH; Paradkar A
    Int J Pharm; 2005 Apr; 294(1-2):161-71. PubMed ID: 15814241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hexagonal Liquid Crystalline Nanodispersions Proven Superiority for Enhanced Oral Delivery of Rosuvastatin: In Vitro Characterization and In Vivo Pharmacokinetic Study.
    Gabr MM; Mortada SM; Sallam MA
    J Pharm Sci; 2017 Oct; 106(10):3103-3112. PubMed ID: 28479357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration.
    Nguyen TH; Hanley T; Porter CJ; Boyd BJ
    J Control Release; 2011 Jul; 153(2):180-6. PubMed ID: 21497623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin ocular delivery systems based on glycerol monooleate reversed hexagonal and reversed cubic liquid crystalline phases.
    Milak S; Chemelli A; Glatter O; Zimmer A
    Eur J Pharm Biopharm; 2019 Jun; 139():279-290. PubMed ID: 31002864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the gastrointestinal transit of lipid-based liquid crystalline systems using whole-animal imaging.
    Pham AC; Nguyen TH; Nowell CJ; Graham B; Boyd BJ
    Drug Deliv Transl Res; 2015 Dec; 5(6):566-74. PubMed ID: 26328930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and evaluation of novel solid nanodispersion system for oral delivery of poorly water-soluble drugs.
    Nkansah P; Antipas A; Lu Y; Varma M; Rotter C; Rago B; El-Kattan A; Taylor G; Rubio M; Litchfield J
    J Control Release; 2013 Jul; 169(1-2):150-61. PubMed ID: 23570985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs.
    Lee KW; Nguyen TH; Hanley T; Boyd BJ
    Int J Pharm; 2009 Jan; 365(1-2):190-9. PubMed ID: 18790030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of multiparticulate vaginal tablet using glyceryl monooleate for sustained progesterone delivery.
    Biradar SV; Dhumal RS; Shah MH; Paradkar AR; Yamamura S
    Pharm Dev Technol; 2009; 14(1):38-49. PubMed ID: 18802845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.